SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,627.23 20.48
( 0.03%)

Global Indices

Nasdaq

52,379.88 143.72
(0.28%)

Dow Jones

7,698.05 53.37
(0.70%)

Hang Seng

63,411.54 1,221.89
(1.96%)

Nikkei 225

10,766.40 76.04
(0.71%)

Forex

USD-INR

94.93 0.33
(0.34%)

EUR-INR

106.36 0.18
(0.17%)

GBP-INR

126.93 0.23
(0.18%)

JPY-INR

0.61 0.00
(0.53%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sat Kartar Life Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93343

INE0NB801022

43.3828165

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SATKARTAR

12.77

203.36

EPS(TTM)

Face Value()

Div & Yield %

10.08

0.54

Back

Cipla consolidated net profit declines 39.19% in the June 2026 quarter

Jul 23,2026

Net profit of Cipla declined 39.19% to Rs 789.05 crore in the quarter ended June 2026 as against Rs 1297.62 crore during the previous quarter ended June 2025. Sales rose 3.51% to Rs 7077.02 crore in the quarter ended June 2026 as against Rs 6837.04 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	7077.02	6837.04	4
OPM %	16.85	26.01	-
PBDT	1386.17	2022.65	-31
PBT	1081.93	1769.93	-39
NP	789.05	1297.62	-39

73,627.23 20.48 ( 0.03%)

52,379.88 143.72 (0.28%)

7,698.05 53.37 (0.70%)

63,411.54 1,221.89 (1.96%)

10,766.40 76.04 (0.71%)

94.93 0.33 (0.34%)

106.36 0.18 (0.17%)

126.93 0.23 (0.18%)

0.61 0.00 (0.53%)